Schonfeld Strategic Advisors LLC
Position in SLN — Silence Therapeutics plc
CIK 1665241
NEW YORK, NY
Position in SLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,957,441
+$2,534,453 QoQ
Shares Held
269,348
+79.6% QoQ
Ownership
0.433%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#19
of 72 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. SLN ranks #44 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in SLN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,957,441 | 269,348 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $422,988 | 149,996 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $847,616 | 123,200 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,017,880 | 166,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,425,703 | 75,037 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,872,800 | 133,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $854,604 | 49,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $455,648 | 46,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $258,500 | 47,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $254,820 | 41,100 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $449,875 | 29,500 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||